Skip to main content
. 2018 Oct 29;19(6):341–345. doi: 10.1002/acm2.12481

Table 1.

Summary of biological effective dose to organs at risk

Priority Organ α/β BED metric BED1 BED1_onCT2 BED2 BED sum Cumulative dose limits
BED (Gyα/β) Physical (Gy/4 fx)
1 Spinal canal 2 D max (Gy2) 47.2 46.9 12.1 47.1 D max < 110.5 D max < 26
2 PBTa 3 D max (Gy3) 21.8 21.5 32.2 34.7 D max < 135.7 D max < 34.8
3 Esophagus 3 D max (Gy3) 100.5 104.3 12.7 104.4 D max < 105 D max < 30
4 Lungs‐PTVb 3 V 53.3Gy3 (%) 3.5 1.8 1.3 3.3 V 53.3 < 10% V20 < 10%
5 Heart 3 D max (Gy3) 104.6 107.8 40.5 107.9 D max < 130.3 D max < 34
6 Skin 3 D max (Gy3) 47.3 48.5 99.5 105.0 D max < 144 D max < 36

BED1 doses are reported using CT1 contours.

BED1_onCT2 doses are reported using CT2 contours after warping BED1 onto CT2.

BED2 and BED sum doses are reported using CT2 contours.

a

PBT, proximal bronchial tree.

b

Lungs‐PTV contours are different in CT1 and CT2 due to different PTVs.